Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPET

NCT01109992 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Exercise plus Regadenoson (Lexercise)
DRUG: Regadenoson (Lexiscan)

Sponsor

Brigham and Women's Hospital